Abstract The applications of 2-deoxy-2-[18 F] fluoro-d-glucose positron emission
tomography/X-ray computed tomography (PET/CT) in the management of patients with …

Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only about
2% to 4% of all breast cancer cases in the United States. 1 Despite its low incidence, IBC …

Background We performed a systematic review and meta-analysis to evaluate the
prognostic significance of 18 F-FDG PET and PET/CT for evaluation of responses to …

Objectives The aim of this meta-analysis was to evaluate the accuracy of 18 F-FDG PET/CT
in predicting the pathological response to neoadjuvant chemotherapy (NAC) in breast …

Purpose The aim of this study was to develop a combined statistical model using both
clinicopathological factors and texture parameters from 18 F-FDG PET/CT to predict …

Metabolic reprogramming is not only an emerging hallmark of cancer, but also an essential
regulator of cancer cell adaptation to the microenvironment. Metabolic imaging targeting …

Breast cancer is the most common cancer among women in the United States and the
second leading cause of cancer-related deaths; approximately 12.9% of women will be …

Introduction Reliable predictive markers are lacking for resectable non-small cell lung
cancer (NSCLC) patients treated with neoadjuvant chemoimmunotherapy. The present …

Backgrounds: The aim of this study was to evaluate the clinical usefulness of radiomics
signatures derived 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography …

Background Inflammatory breast cancer (IBC) is a rare and aggressive disease treated with
multimodality therapy: preoperative systemic therapy (PST) followed by modified radical …